Article Information
History
- December 11, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Anna A Mensah, MSc1,
- Helen Campbell, PhD1,*,
- Julia Stowe, PhD1,
- Giulia Seghezzo, MSc2,
- Ruth Simmons, PhD1,
- Joanne Lacy, MSc1,
- Antoaneta Bukasa, MSc1,
- Shennae O’Boyle, MSc1,
- Mary E Ramsay, FFPH1,
- Kevin Brown, FRCPath1 and
- Shamez Ladhani, PhD1
- 1Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK
- 2COVID-19 EpiCell, UK Health Security Agency, London, UK
- ↵*CORRESPONDING AUTHOR
Dr Helen Campbell, Immunisation and vaccine preventable Division, UK Health Security Agency Colindale, London NW9 5EQ, UK. Email: Helen.Campbell{at}phe.gov.uk